Europe's Leading Biopartnering and Investment Conference
Now in its 11th year, the aim of BioTrinity is simple - create an ideal networking and partnering platform for life science companies across the world to meet all under one roof and catalyse business in the industry, to ultimately help shape our healthcare future. BioTrinity offers unique access to global life science investors, big pharma executives and innovative CEO's of emerging R&D companies seeking to make deals and grow their networks. Nigel Davis, CEO Medherant, will be attending and presenting at this conference.
8th May to 10th May 2017